PIK3CA and neoplasm: This observation would be consistent with an eventual loss of triallelic-mutant cells (PTEN-null and PIK3CA* positive), potentially due to an innate tumor-suppressing mechanism that blocks the propagation of cells containing excessive PIP3 by arresting growth and/or promoting apoptosis (19, , –22).